Further characterization of the metabolic properties of triglyceride- rich lipoproteins from human and mouse apoC-III transgenic mice

Journal of Lipid Research

Volumn 37, Issue 8, 1996, Pages 1802-1811

  Aalto Setälä, Katriina ^a,b   Weinstock, Peter H ^a   Bisgaier, Charles L ^c   Wu, Lin ^a   Smith, Jonathan D ^a   Breslow, Jan L ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c PFIZER INC   (United States)

Author keywords

apolipoprotein C III; apolipoprotein E; lipoprotein lipase; transgenic mice; very low density lipoproteins; vitamin A

Indexed keywords

APOLIPOPROTEIN C3; APOLIPOPROTEIN E; LIPOPROTEIN; LIPOPROTEIN LIPASE; PROTEOHEPARAN SULFATE; RETINOL; RNA; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL TRANSPORT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN METABOLISM; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; TRANSGENIC MOUSE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; DIETARY FATS; FASTING; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; HYPERTRIGLYCERIDEMIA; LIPIDS; LIPOPROTEINS, VLDL; MALE; MICE; MICE, TRANSGENIC; POSTPRANDIAL PERIOD; RNA, MESSENGER; TIME FACTORS; TRANSGENES; TRIGLYCERIDES; VITAMIN A;

EID: 0029791717     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Schonfeld, G., P. K. George, J. Miller, P. Reilly, and J. Witztum. 1979. Apolipoprotein C-II and C-III levels in hyperlipoproteinemia. Metab. Clin. Exp. 28: 1001-1010.
2. Shoulders, C. C., P. J. Harry, L. Lagrost, S. E. White, N-F. Shah, J. D. North, M. Gilligan, P. Gambert, and M. J. Ball. 1991. Variation at the apoAI/CIII/AIV gene complex is associated with elevated plasma levels of apoC-III. Atherosclerosis. 87: 239-247.
3. Le, N-A., J. C. Gibson, and H. N. Ginsberg. 1988. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins. J. Lipid Res. 29: 669-677.
4. Rees, A., J. Stocks, C. R. Sharpe, M. A. Vella, C. C. Shoulders, J. Katz, N. I. Jowett, F. E. Baralle, and D. J. Galton. 1985. Deoxyribonucleic acid polymorphism in the apolipoprotein A-I-C-III gene cluster. Association with hypertriglyceridemia. J. Clin. Invest. 76: 1090-1095.
5. Aalto-Setälä, K., K. Kontula, T. Sane, M. Nieminen, and E. Nikkilä. 1987. DNA polymorphism of apolipoprotein A-I/C-III and insulin genes in familial hypertriglyceridemia and coronary heart disease. Atherosclerosis. 66: 145-152.
6. Tas, S. 1989. Strong association of a single nucleotide substitution in the 3′ untranslated region of the apolipoprotein C-III gene with common hypertriglyceridemia in Arabs. Clin. Chem. 35: 256-259.
7. Ordovas, J. M., F. Civeira, J. Genets, Jr., S. Graig, A. H. Robbins, T. Meade, M. Pocovi, P. M. Frossard, U. Masharani, P. W. F. Winson, D. N. Salem, R. H. Ward, and E. J. Schaefer. 1991. Restriction fragment length polymorphism of the apolipoproteins A-I, C-III, A-IV gene locus: relationships with lipids, apolipoproteins, and premature coronary artery disease. Atherosclerosis. 87: 75-86.
8. Ahn, Y. I., R. Valdez, A. P. Reddy, S. A. Cole, K. M. Weiss, and R. E. Ferrell. 1991. DNA polymorphisms of the apolipoprotein A-I/C-III/A-IV gene cluster influence plasma cholesterol and triglyceride levels in Mayans of the Yucatan Peninsula, Mexico. Hum. Hered. 41: 281-289.
9. Zeng, Q., M. Dammerman, Y. Takada, A. Matsunage, J. L. Breslow, and J. Sasaki. 1994. An apolipoprotein C-III marker associated with hypertriglyceridemia in Caucasions also confers increased risk in a west Japanese population. Hum. Genet. 95: 371-375.
10. Brown, V., and M. L. Baginsky. 1972. Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein. Biochim. Biophys. Acta. 46: 375-382.
11. Krauss, R. M., P. N. Herbert, R. I. Levy, and D. S. Fredrickson. 1973. Further observations on the activation and inhibition of lipoprotein lipase by apolipoproteins. Circ. Res. 33: 403-411.
12. Jackson, R. L., S. Tajima, T. Yamamura, S. Yokoyama, and A. Yamamoto. 1986. Comparison of apolipoprotein C-II-defident triacylglycerol-rich lipoproteins and trioleoylglycerol/phosphotidylcholine-stabilized particles as substrates for lipoprotein lipase. Biochim. Biophys. Acta. 875: 211-219.
13. Windler, E., and R. J. Havel. 1985. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver. J. Lipid Res. 26: 556-565.
14. Quarfordt, S. H., G. Michalopoulus, and B. Schirmer. 1882. The effects of human C apolipoproteins on the in vitro hepatic metabolism of triglyceride emulsions in the rat. J. Biol. Chem. 257: 14642-14647.
15. Shelburne, F., J. Hanks, W. Meyers, and S. Quarfordt. 1980. Effect of apolipoproteins on hepatic uptake of triglyceride emulsion in the rat. J. Clin. Invest. 65: 652-658.
16. Ito, Y., N. Azrolan, A. O'Connell, A. Walsh, and J. L. Breslow. 1990. Hypertriglyceridemia as a result of human apolipoprotein C-III gene expression in transgenic mice. Science. 249: 790-793.
17. Aalto-Setälä, K., E. A. Fisher, X. Chen, T. Chajek-Shaul, T. Hayek, R. Zechner, A. Walsh, R. Ramakrishnan, H. N. Gilnsberg, and J. L. Breslow. 1992. Mechanism of hypertriglyceridemia in human apolipoprotein (apo) C-III transgenic mice: diminished very low density lipoprotein fractional catabolic rate associated with increased apoC-III and reduced apoE on the particles. J. Clin. Invest. 90: 1889-1900.
18. de Silva, H. V., S. J. Lauer, J. Wang, W. S. Simonett, K. H. Weisgraber, R. W. Mahley, and J. M. Taylor. 1994. Over-expression of human apolipoprotein C-III in transgenic mice results in accumulation of apolipoprotein B-48 remnant that is corrected by excess apolipoprotein E.J. Biol. Chem. 269: 2324-2335.
19. Maeda, N., H. Li, D. Lee, P. Oliver, S. H. Quarfordt, and J. Osada. 1994. Targeted distribution of the apolipoprotein C-III gene in mice results in hypertriglyceridemia and protection from postprandial hypertriglyceridemia. J. Biol. Chem. 269: 23610-23616.
20. Breslow, J. L. 1989. Familial disorders of high density lipoprotein metabolism. In The Metabolic Basis of Inherited Disease. 6th ed. C. Scriver, A. Sly, and D. Valle, editors. McGraw-Hill, Inc., New York. 1251-1266.
21. Smith, J. D., A. S. Plump, T. Hayek, A. Walsh, and J. L. Breslow. 1990. Accumulation of human apolipoprotein E in the plasma of transgenic mice. J. Biol. Chem. 265: 14709-14712.
22. Januzzi, J. L., N. Azorolan, A. O'Connell, K. Aalto-Setälä, and J. L. Breslow. 1992. Characterization of the mouse apolipoproteins Apoa-1/ApoC-3 gene locus: genomic, mRNA, and protein sequences with comparisons to other species. Genomics. 14: 1081-1088.
23. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
24. Walsh, A., N. Azrolan, K. Wang, A. Marcifliano, A. O'Connell, and J. L. Breslow. 1993. Intestinal expression of the human apoA-I gene in transgenic mice is controlled by a DNA region 3′ to the gene in the promoter of the adjacent convergently transcribed apoC-III gene. J. Lipid Res. 34: 617-623.
25. Kieft, K. A., T. M. A. Bocan, and B. R. Krause. 1991. Rapid on-line determination of cholesterol distribution among plasma lipoproteins after high-performance gel-filtration chromatography. J. Lipid Res. 32: 859-866.
26. Haubenwallner, S., A. D. Essenburg, B. C. Barnett, M. E. Pape, R. B. DeMattos, B. R. Krause, L. L. Minton, B. J. Auerbach, R. S. Newton, T. Leff, and C. L. Bisgaier. 1995. Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action. J. Lipid Res. 36: 2541-2551.
27. Weber, K., and M. Osborn. 1969. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J. Biol. Chem. 244: 4406-4412.
28. Aalto-Selälä, K., C. L. Bisgaier, A. Ho, K. A. Kieft, M. G. Traber, H. J. Kayden, R. Ramakrishnan, A. Walsh, A. D. Essenburg, and J. L. Breslow. 1994. Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior. J. Clin. Invest. 93: 1776-1786.
29. Kates, M., B. Palameta, C. N. Joo, D.J. Kushner, and N. E. Gibbons. 1966. Aliphatic diether analogs of glyceride-derived lipids. IV. The occurrence of de-O-dehydrophytyl-glycerol ether containing lipids in extremely halophilic bacteria. Biochemistry. 5: 4092-4099.
30. Weintraub, M. S., S. Eisenberg, and J. L. Breslow. 1987. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. J. Clin. Invest. 79: 1110-1119.
31. Adams, R. L. P. 1980. Laboratory techniques in biochemistry and molecular biology: cell culture for biochemists. T. S. Work and R. H. Burton, editors. Elsevier Biomedical Press, Amsterdam. 11-137.
32. Ellsworth, J. L., S. K. Erikson, and A. D. Cooper. 1986. Very low density lipoprotein synthesis and secretion by the human hepatoma cell line Hep-G2: effects of free fatty acid. J. Lipid Res. 27: 858-874.
33. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 267-275.
34. Shachter, N. S., T. Hayek, T. Leff, J. D. Smith, D. W. Rosenberg, A. Walsh, R. Ramakrishnan, I. J. Goldberg, H. N. Ginsberg, and J. L. Breslow. 1994. Overexpression of apolipoprotein C-II causes hypertriglyceridemia in transgenic mice. J. Clin. Invest. 93: 1683-1690.
35. Plump, A. S., J. D. Smith, T. Hayek, K. Aalto-Setälä, A. Walsh, J. G. Verstuyft, E. M. Rubin, and J. L. Breslow. 1992. Severe hypercholesterolemia in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71: 1-20.
36. LaRosa J. C., L. E. Chambless, M. H. Criqui, I. D. Frantz, C. J. Glueck, G. Heiss, and J. A. Morrison. 1986. Patterns of dyslipoproteinemia in selected North American populations. The Lipid Research Clinics Program Prevalance Study. Circulation. 73: Suppl. 1. 12-29.
37. Fojo, S. S., J. L. de Gennes, U. Beisiegel, G. Baggio, S. F. Stahlenhoef, J. D. Brunzell, and H. B. Brewer, Jr. 1991. Molecular genetics of apoC-II and lipoprotein lipase deficiency. Adv. Exp. Med. Biol. 285: 329-333.
38. Brunzell, J. D. 1995. Familial lipoprotein lipase deficiency and other causes of chylomicronemia syndromes. In The Metabolic Basis of Inherited Disease. 6th ed. C. Scriver, A. Sly and D. Valle, editors. McGraw-Hill, Inc., New York. 1913-1932.
39. Coleman, T., R. L. Seip, J. M. Gimbles, D. Lee, N. Maeda, and C. F. Semenkovich. 1995. COOH-terminal distribution of lipoprotein lipase in mice is lethal in homozygotes, but heterozygotes have elevated triglycerides and impaired enzyme activity. J. Biol. Chem. 270: 12518-12525.
40. Weinstock, P. H., C. L. Bisgaier, K. Aalto-Setälä, H. Radner, R. Ramakrishnan, S. Levak-Frank, A. D. Essenburg, R. Zechner, and J. L. Breslow. 1995. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice: mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J. Clin. Invest. 96: 2555-2568.
41. Chen, M., J. L. Breslow, W. Li, and T. Leff. 1994. Transcriptional regulation of the apoC-III gene by insulin is diabetic mice: correlation with changes in plasma triglyceride levels. J. Lipid Res. 35: 1918-1924.
42. Li, W. W., M. M. Dammerman, J. D. Smith, S. Metzger, J. L. Breslow, and T. Leff. 1995. Common genetic variation in the promoter of the human apoC-III gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J. Clin. Invest. 96: 2601-2605.
43. Dammerman, M., L. A. Sandkuijl, J. L. Halaas, W. Chung, and J. L. Breslow. 1993. An apolipoprotein C-III haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc. Natl. Acad. Sci. USA. 90: 4562-4566.